Craig Eagle Guardant Health, Inc. (GH) insider trading activity

Craig Eagle is Chief Medical Officer of Guardant Health, Inc.. Currently has a direct ownership of 23,962 shares of GH, which is worth approximately $758,876. The most recent transaction as insider was on Dec 15, 2024, when has been sold 711 shares (Common Stock) at a price of $34.76 per share, resulting in proceeds of $24,714. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24K

24.89% 3M change

156.33% 12M change

Total Value Held $758,876

CRAIG EAGLE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 15 2024	SELL Payment of exercise price or tax liability	$24,714 $34.76 p/Share	711 Reduced 2.88%	23,962 Common Stock
Dec 15 2024	BUY Exercise of conversion of derivative security	-	1,402 Added 5.38%	24,673 Common Stock
Oct 01 2024	SELL Payment of exercise price or tax liability	$92,904 $22.12 p/Share	4,200 Reduced 15.29%	23,271 Common Stock
Oct 01 2024	BUY Exercise of conversion of derivative security	-	8,284 Added 23.17%	27,471 Common Stock
Sep 15 2024	SELL Payment of exercise price or tax liability	$19,047 $26.79 p/Share	711 Reduced 3.57%	19,187 Common Stock
Sep 15 2024	BUY Exercise of conversion of derivative security	-	1,402 Added 6.58%	19,898 Common Stock
Jul 01 2024	SELL Payment of exercise price or tax liability	$17,295 $28.26 p/Share	612 Reduced 3.2%	18,496 Common Stock
Jul 01 2024	BUY Exercise of conversion of derivative security	-	1,714 Added 8.23%	19,108 Common Stock
Jun 15 2024	SELL Payment of exercise price or tax liability	$59,543 $30.21 p/Share	1,971 Reduced 10.18%	17,394 Common Stock
Jun 15 2024	BUY Exercise of conversion of derivative security	-	5,523 Added 22.19%	19,365 Common Stock
May 15 2024	SELL Payment of exercise price or tax liability	$34,170 $25.75 p/Share	1,327 Reduced 8.75%	13,842 Common Stock
May 15 2024	BUY Exercise of conversion of derivative security	-	3,717 Added 19.68%	15,169 Common Stock
Apr 01 2024	SELL Payment of exercise price or tax liability	$12,575 $20.25 p/Share	621 Reduced 5.14%	11,452 Common Stock
Apr 01 2024	BUY Exercise of conversion of derivative security	-	1,714 Added 12.43%	12,073 Common Stock
Jan 01 2024	SELL Payment of exercise price or tax liability	$19,016 $27.05 p/Share	703 Reduced 6.36%	10,359 Common Stock
Jan 01 2024	BUY Exercise of conversion of derivative security	-	1,714 Added 13.42%	11,062 Common Stock
Oct 01 2023	SELL Payment of exercise price or tax liability	$70,276 $29.64 p/Share	2,371 Reduced 20.23%	9,348 Common Stock
Oct 01 2023	BUY Exercise of conversion of derivative security	-	6,856 Added 36.91%	11,719 Common Stock
May 15 2023	SELL Payment of exercise price or tax liability	$35,866 $27.89 p/Share	1,286 Reduced 20.91%	4,863 Common Stock
May 15 2023	BUY Exercise of conversion of derivative security	-	3,718 Added 37.68%	6,149 Common Stock
May 15 2022	SELL Payment of exercise price or tax liability	$46,180 $35.91 p/Share	1,286 Reduced 34.6%	2,431 Common Stock
May 15 2022	BUY Exercise of conversion of derivative security	-	3,717 Added 50.0%	3,717 Common Stock

Also insider at

MYMD

MyMD Pharmaceuticals, Inc. Healthcare

Director

Craig Eagle

Chief Medical Officer

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GH shares.

Notify only if

Value

Insider Trading

Get notified when an Guardant Health, Inc. insider buys or sells GH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Guardant Health, Inc.

Track Activities on GH

Account